BioCatalystWatch
COYAWorkspace / COYA / OverviewCompany library
Coya Therapeutics, Inc. logo

Coya Therapeutics, Inc.

Coya Therapeutics, Inc. (COYA)

Website

Price
Market cap
Next catalystNovember 2026, as the first cohort completes the 48-week treatment periodCOYA 302 — ALSTARS · Trial initiationCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

COYA 302

CD80

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

COYA 302

CD80

PreINDP1P3FilingApproved
Upcoming / outlook

COYA 303

IL-2Rα (CD25) × GLP-1 receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

COYA 303

IL-2Rα (CD25) × GLP-1 receptor

PreINDP1P2P3FilingApproved

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

COYA 303

IL-2Rα (CD25) × GLP-1 receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

COYA 302

CD80

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

COYA 302

CD80

PreINDP1P3FilingApproved
Upcoming / outlook

COYA 303

IL-2Rα (CD25) × GLP-1 receptor

PreINDP1P2P3FilingApproved

Other pipelines

COYA 201

PreINDP1P2P3FilingApproved
COYA 301

PreINDP1P2P3FilingApproved
COYA 206

PreINDP1P2P3FilingApproved

Partner / License out

COYA 302

CD80

COYA 302

CD80

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

COYA PR & News

PR & News

COYA SEC archive